Metraipolis › archive › dc_89b8bef3ceb5
Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42151560
- DOI
- 10.1038/s41416-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T05:27:17.683Z
- SHA-256 of the archived text
b09e1be3246368dc9cb9d2ad3aa791385cb134896c0f5a089cadea7843d0fe8b- Stable URL of this page
https://metraipolis.com/documento/dc_89b8bef3ceb5
How to cite
Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560 — Europe PMC (en), https://europepmc.org/article/MED/42151560 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89b8bef3ceb5 (Metraipolis archive dc_89b8bef3ceb5, sha256 b09e1be3246368dc9cb9d2ad3aa791385cb134896c0f5a089cadea7843d0fe8b)
BibTeX
@misc{dc89b8bef3ceb5,
title = {Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42151560},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89b8bef3ceb5; sha256 b09e1be3246368dc9cb9d2ad3aa791385cb134896c0f5a089cadea7843d0fe8b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42151560. Agents can read the archived copy with the MCP tool read_document.